These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24500564)

  • 21. Association of adiponectin with cardiovascular events in diabetic and non-diabetic hemodialysis patients.
    Elokely A; Shoukry A; Ghonemy TA; Atia M; Amr G
    Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):736-42. PubMed ID: 22805386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
    Kendall DM; Harmel AP
    Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials.
    Haffner SM
    Int J Clin Pract Suppl; 2002 Jul; (129):33-9. PubMed ID: 12166604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The thrifty 'catch-up fat' phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome.
    Dulloo AG; Jacquet J; Seydoux J; Montani JP
    Int J Obes (Lond); 2006 Dec; 30 Suppl 4():S23-35. PubMed ID: 17133232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium signalling and ER stress in insulin resistance and atherosclerosis.
    Ozcan L; Tabas I
    J Intern Med; 2016 Nov; 280(5):457-464. PubMed ID: 27739133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of macrovascular complications in diabetes.
    Fumeron F; Reis AF; Velho G
    Curr Diab Rep; 2006 Apr; 6(2):162-8. PubMed ID: 16542628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does microRNA Perturbation Control the Mechanisms Linking Obesity and Diabetes? Implications for Cardiovascular Risk.
    La Sala L; Crestani M; Garavelli S; de Candia P; Pontiroli AE
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular complications of type 2 diabetes in youth.
    Kehler DS; Stammers AN; Susser SE; Hamm NC; Kimber DE; Hlynsky MW; Duhamel TA
    Biochem Cell Biol; 2015 Oct; 93(5):496-510. PubMed ID: 25629355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective.
    Conte M; Franceschi C; Sandri M; Salvioli S
    Trends Endocrinol Metab; 2016 Dec; 27(12):893-903. PubMed ID: 27659144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The C1q/TNF-related proteins (CTRPs) in pathogenesis of obesity-related metabolic disorders: Focus on type 2 diabetes and cardiovascular diseases.
    Shanaki M; Shabani P; Goudarzi A; Omidifar A; Bashash D; Emamgholipour S
    Life Sci; 2020 Sep; 256():117913. PubMed ID: 32526287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications.
    Murea M; Ma L; Freedman BI
    Rev Diabet Stud; 2012; 9(1):6-22. PubMed ID: 22972441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nutritional programming of insulin resistance: causes and consequences.
    Duque-Guimarães DE; Ozanne SE
    Trends Endocrinol Metab; 2013 Oct; 24(10):525-35. PubMed ID: 23791137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress in diabetes: implications for vascular and other complications.
    Pitocco D; Tesauro M; Alessandro R; Ghirlanda G; Cardillo C
    Int J Mol Sci; 2013 Oct; 14(11):21525-50. PubMed ID: 24177571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Network-Based Association Study of Obesity and Type 2 Diabetes with Gene Expression Profiles.
    Zhang S; Wang B; Shi J; Li J
    Biomed Res Int; 2015; 2015():619730. PubMed ID: 26273637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are the available experimental models of type 2 diabetes appropriate for a gender perspective?
    Franconi F; Seghieri G; Canu S; Straface E; Campesi I; Malorni W
    Pharmacol Res; 2008 Jan; 57(1):6-18. PubMed ID: 18221886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Therapeutic Effects of Exogenous Ketone Supplementation for Type 2 Diabetes: A Review.
    Walsh JJ; Myette-Côté É; Neudorf H; Little JP
    Curr Pharm Des; 2020; 26(9):958-969. PubMed ID: 32013822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular complications in diabetes: lessons from animal models.
    Potenza MA; Nacci C; Gagliardi S; Montagnani M
    Curr Med Chem; 2011; 18(12):1806-19. PubMed ID: 21466471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of obesity-induced type 2 diabetes on long-term outcomes following stroke.
    Bhaskar S
    Clin Sci (Lond); 2019 Jul; 133(14):1603-1607. PubMed ID: 31331992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 2 diabetes-an introduction to the development and use of animal models.
    Kaplan JR; Wagner JD
    ILAR J; 2006; 47(3):181-5. PubMed ID: 16804193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic Risk.
    Terenzi DC; Trac JZ; Teoh H; Gerstein HC; Bhatt DL; Al-Omran M; Verma S; Hess DA
    Trends Mol Med; 2019 Jul; 25(7):640-655. PubMed ID: 31053416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.